Company
United StatesReproductive Institute of South Texas, Mcallen, TX – FDA Inspections
Inspection records and compliance data for Reproductive Institute of South Texas in Mcallen, Texas. 5 FDA inspections on record (1 OAI), 1 Form 483, last inspected July 11, 2022.
Company Profile
This profile covers Reproductive Institute of South Texas based in Mcallen, Texas, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 1
- VAI
- 3
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected August 10, 2012. Last inspected July 11, 2022.
Most cited issue areas
- Risk factors, clinical evidence3 inspections
- Accurate, indelible, legible2 inspections
- Infection with communicable disease agents2 inspections
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 11, 2022 | NAI | Biologics · Blood and Blood Products | 1175277 |
| April 16, 2018 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1048356 |
| January 7, 2016 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 960804 |
| August 16, 2013 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 844699 |
| August 10, 2012 | OAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 794470 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Reproductive Institute of South Texas
FEI Number
3004611200
Address
110 E Savannah Ave Bldg B Ste 103, Mcallen, Texas 78503, United States
Country
United States
ID: a76aeb12-7e06-4968-a6ae-6fe3eac45f0d